February 2016 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology”
A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.
Scientists discovered a new Tcelltreatmentthat could regrow hair. Users are skeptical but hopeful, with some relying on finasteride and minoxidil in the meantime.
Pelage is developing a topical hair follicle stem celltherapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.
Rosemary extract showed high inhibitory activity against DHT, similar to finasteride and dutasteride, butthe conversation includes skepticism about its effectiveness in humans since the study was done on mice and rosemary oil is often considered ineffective based on personal experiences. Some suggesttrying rosemary oil alongside other treatments, while others emphasize the difference between the extract used in the study and the oil.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.